Document Detail


Metabolic responses to change in disease activity during Tumor Necrosis Factor inhibition in patients with Rheumatoid Arthritis.
MedLine Citation:
PMID:  22574709     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objectives: Assessment of disease activity in patients with rheumatoid arthritis (RA) is of importance in the evaluation of treatment. The most important measure of disease activity is the Disease Activity Score counted in 28 joints (DAS28). In this study we evaluated whether metabolic profiling could complement current measures of disease activity. Methods: Fifty-six patients, in two separate studies, were followed for two years after commencing anti-TNF therapy. DAS28 was assessed and metabolic profiles recorded at defined time points. Correlations between metabolic profile and DAS28 scores were analyzed using multivariate statistics. Results: The metabolic responses to lowering DAS28 scores varied in different patients, but could predict DAS28 scores at the individual and subgroup level models. The erythrocyte sedimentation rate (ESR) component in DAS28 was most correlated to the metabolite data, pointing to inflammation as the primary effect driving metabolic profile changes. Conclusions: Patients with RA had differing metabolic response to changes in DAS28 following anti-TNF therapy. This suggests that discovery of new metabolic biomarkers for disease activity will derive from studies at the individual and subgroup level. Increased inflammation, measured as ESR, was the main common effect seen in metabolic profiles from periods associated with high DAS28.
Authors:
Rasmus Madsen; Solbritt Rantapää-Dahlqvist; Torbjörn Lundstedt; Thomas Moritz; Johan Trygg
Related Documents :
2886319 - Liver metabolism of budesonide in rat, mouse, and man. comparative aspects.
9118889 - Species differences in the metabolism of benzene.
15980099 - Metabolism of the one-ring open metabolites of the cardioprotective drug dexrazoxane to...
12162719 - Abnormal alterations in the metabolic patterns of patients on valproate therapy.
19678709 - Serum metabolite profiling of human colorectal cancer using gc-tofms and uplc-qtofms.
2939259 - A chemiluminescent immunoassay for zeranol and its metabolites.
20122449 - Sports-related issues and biochemistry of natural and synthetic anabolic substances.
22009159 - Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
7378909 - Lack of effect of botulinum toxin on nonadrenergic, noncholinergic inhibitory responses...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-10
Journal Detail:
Title:  Journal of proteome research     Volume:  -     ISSN:  1535-3907     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101128775     Medline TA:  J Proteome Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Knee joint neuromuscular activation performance during muscle damage and superimposed fatigue.
Next Document:  The association of blood transfusion with mortality after cardiac surgery: cause or confounding?